GlassScriptPhysician profile
Steven Kurtz
NPI 1649843590
$1,051.78
in general payments reported to CMS, 2019-2025
19 companies · $39.45 in 2025
The $39.45 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $570 · 2022: $59.20 · 2023: $60.90 · 2024: $322 · 2025: $39.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $259 · Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $259.12 |
| Food and Beverage | $163.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $259.12 | 2024 | Interstim |
| Abbott Laboratories | $140.16 | 2021 | |
| Novo Nordisk INC | $132.37 | 2021 | |
| Dexcom, INC. | $113.12 | 2021-2024 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $62.70 | 2021-2022 | |
| Zealand Pharma US, INC. | $42.92 | 2021 | |
| Sanofi-Aventis U.S. LLC | $37.10 | 2021 | |
| Corcept Therapeutics | $34.44 | 2021 | |
| Abbvie INC. | $30.67 | 2021 | |
| Mannkind Corporation | $29.11 | 2021 | |
| Gilead Sciences, INC. | $25.01 | 2023 | |
| Hologic Sales and Service, LLC | $23.78 | 2025 | Aptima |
| Merck Sharp & Dohme LLC | $22.43 | 2023 | Zerbaxa, Dificid, Recarbrio |
| Immunitybio, INC. | $21.59 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $17.93 | 2024 | Breztri |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.68 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $15.67 | 2025 | Rexulti |
| Radius Health, INC. | $13.64 | 2021 | |
| Ibsa Pharma INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kurtz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.